维普中文期刊产品整合服务
315篇 您的检索式:作者名="Anaissi"
    题名 作者 年代 出处 被引量
1hsa-miR-29c and hsa-miR-135b differential expression aspotential biomarker of gastric carcinogenesis显示文摘AIM: To investigate the expression profiles of hsa-mi R-29 c and hsa-mi R-135 b in gastric mucosal samples and their values as gastric carcinogenesis biomarkers. METHODS: The expression levels of hsa-mi R-29 c and hsa-mi R-135 b in normal gastric mucosa, non-atrophic chronic gastritis, intestinal metaplasia and intestinaltype gastric adenocarcinoma were analysed using quantitative real-time PCR. The difference between hsa-mi R-29 c and hsa-mi R-135 b expression profiles in the grouped samples was evaluated by ANOVA and Student's t-test tests. The results were adjusted for multiple testing by using Bonferroni's correction. P values ≤ 0.05 were considered statistically significant. To evaluate hsa-mi R-29 c and hsa-mi R-135 b expressions as potential biomarkers of gastric carcinogenesis, we performed a receiver operating characteristic curve analysis and the derived area under the curve, and a Categorical Principal Components Analysis. In silico identification of the genetic targets of hsa-mi R-29 c and hsa-mi R-135 b was performed using different prediction tools, in order to identify possible genes involved in gastric carcinogenesis.RESULTS: The expression levels of hsa-mi R-29 c were higher in normal gastric mucosal samples, and decreased progressively in non-atrophic chronic gastritis samples, intestinal metaplasia samples and intestinal-type gastric adenocarcinoma samples. The expression of hsa-mi R-29 c in the gastric lesions showed that non-atrophic gastritis have an intermediate profile to gastric normal mucosa and intestinal-type gastric adenocarcinoma, and that intestinal metaplasia samples presented an expression pattern similar to that in intestinal-type gastric adenocarcinoma. This micro RNA(mi RNA) has a good discriminatory accuracy between normal gastric samples and(1) intestinal-type gastric adenocarcinoma; and(2) intestinal metaplasia, and regulates the DMNT3 A oncogene. hsa-mi R-135 b is up-regulated in non-atrophic chronic gastritis and intestinal metaplasia samples and down-regulated in normal gastric mucosa and intestinal-type gastric adenocarcinoma samples. Non-atrophic chronic gastritis and intestinal metaplasia are significantly different from normal gastric mucosa samples. hsa-mi R-135 b expression presented a greater discriminatory accuracy between normal samples and gastric lesions. This mi RNA was associated with Helicobacter pylori presence in non-atrophic chronic gastritis samples and regulates the APC and KLF4 tumour suppressor genes.CONCLUSION: Our results provide evidence of epigenetic alterations in non-atrophic chronic gastritis and intestinal metaplasia and suggest that hsa-mi R-29 c and hsa-mi R-135 b are promising biomarkers of gastric carcinogenesis.Amanda Ferreira Vidal Aline MP Cruz Leandro Magalhães Adenilson L Pereira Ana KM Anaissi Nélisson CF Alves Paulo JBS Albuquerque Rommel MR Burbano Samia Demachki Ândrea Ribeiro-dos-Santos 2016World Journal of Gastroenterology2016,22,6:7
2Increased risk of deep - vein thrombosis in patients with multiplmyeloma receiving thalidomide and chemotherapy显示文摘Zangari M Anaissie E Barlogic B 2001Blood2001,98,5:1
3Treatment of asperginosis:Clinical prcatice guidelines of the infectious diseases society of America显示文摘Walsh T J Anaissie E J Denning D W 2008Clin Infect Dis2008,46,:1
4The Hospital Water Supply as a Source of Nosocomial Infections A Plea for Action 显示文摘Anaissie EJ Penzak SR Dignani MC 2002Arch Intern Med2002,162,13:1
5Treatment of aspergillosis:clinical practice guidelines of the Infectious Diseases Society of America显示文摘Walsh TJ Anaissie EJ Denning DW 0,,03:1
6The epidemiology of hematogenous candidiasis caused by different Candida species 显示文摘 Anaissie E Hzun O 1997Clin Infect Dis1997,24,:1
7Amphotericin B colloidal dispersion vs amphotericin B as therapy for invasive aspergillosis显示文摘White MH Anaissie EJ Kusne S 1997Clin Inf Dis1997,24,:1
8Treatment of aspergillo- sis: clinical practice guidelines of the Infectious Diseases Society of A- merica 显示文摘Walsh TJ Anaissie E J Denning DW 2008Clin Infect Dis2008,46,:1
9Treatment of aspergillosis:clinical practice guidelines of the Infectious Diseases Society of America显示文摘Walsh TJ Anaissie EJ Denning DW 2008Clin Infect Dis2008,46,3:1
10Predictors of adverse outcome in cancer patients with candidemia显示文摘Anaissie EJ Rex JH Uzun O 1998Am J Med1998,104,:1
11Thalidomide in the management of multiple myeloma 显示文摘Barlogie B Yricot G Anaissie E Semin0,,:1
12Treatment of aspergillosis:clinical practice guidelines of the Infectious Diseases Society of America显示文摘Walsh T J Anaissie E J Denning D W 0,,03:1
13Pathogenic aspergillus species recovered from a hospital water system: a 3-year prospective study显示文摘Anaissie E J Stratton SL Dignani MC 2002Clin Infect Dis2002,34,6:1
14Treatment of as- pergillosis : clinical practice guidelines of the Infectious Diseases Society of America显示文摘Walsh TJ Anaissie E J Denning DW 2008Clin Infect Dis2008,46,3:1
15Treatment of as-pergillosis:clinical practice guidelines of the infectious disea-ses society of america显示文摘Walsh TJ Anaissie EJ Denning DW 2008Clin Infect Dis2008,46,3:1
16The epidemiology of hematogenous candidiasis caused by different Candida species显示文摘Abi-Said D Anaissie E Uzun O 0,,:1
17Treatment of invasive fungal infections in renally impaired patients with amphotericin B colloidal dispersion 显示文摘Anaissie E Mattiuzzi G C Noskin G 2013Antimicrobial Agents & Chemotherapy2013,42,3:1
18Treatment of As pergillosis:Clinical Practice Guidelines of the Infectious Disea ses Society of America显示文摘Walsh TJ Anaissie EJ Denning DW 2008Clinical Infectious Diseases2008,46,3:1
19Treatment of aspergillo- sis: clinical practice guidelines of the Infectious Diseases Society of A- medea 显示文摘Walsh TJ Anaissie EJ Denning DW 2008Clin Infect Dis2008,46,3:1
20Increaseed risk of deep vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy 显示文摘Zangari M Anaissie E Barlogie B 2001Blood2001,98,5:1
返回顶部 每页显示:
共16页 首页 上一页 第1页 下一页 末页 /16 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费